Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Bridging AI innovation and healthcare: scalable clinical validation methods for voice biomarkers.

PMID: 40678717 · 2025

JournalFrontiers in digital health
Year2025
PMID40678717

Abstract

The integration of artificial intelligence (AI) in voice biomarker analysis presents a transformative opportunity for objective and non-invasive diagnostics in healthcare. However, clinical adoption remains limited due to challenges such as data scarcity, model generalizability, and regulatory hurdles. This perspective article explores effective and scalable methods for clinical validation of voice biomarkers, emphasizing the importance of proprietary technology, high-quality, diverse datasets,

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.